These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 15351775)

  • 1. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice.
    Collins AL; Levenson JM; Vilaythong AP; Richman R; Armstrong DL; Noebels JL; David Sweatt J; Zoghbi HY
    Hum Mol Genet; 2004 Nov; 13(21):2679-89. PubMed ID: 15351775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.
    Braunschweig D; Simcox T; Samaco RC; LaSalle JM
    Hum Mol Genet; 2004 Jun; 13(12):1275-86. PubMed ID: 15115765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.
    Guy J; Hendrich B; Holmes M; Martin JE; Bird A
    Nat Genet; 2001 Mar; 27(3):322-6. PubMed ID: 11242117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations.
    Shahbazian MD; Zoghbi HY
    Curr Opin Neurol; 2001 Apr; 14(2):171-6. PubMed ID: 11262731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome.
    Buschdorf JP; Strätling WH
    J Mol Med (Berl); 2004 Feb; 82(2):135-43. PubMed ID: 14618241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of MECP2 mutations in the expression patterns of Rett syndrome patients.
    Ballestar E; Ropero S; Alaminos M; Armstrong J; Setien F; Agrelo R; Fraga MF; Herranz M; Avila S; Pineda M; Monros E; Esteller M
    Hum Genet; 2005 Jan; 116(1-2):91-104. PubMed ID: 15549394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MeCP2 in neurons: closing in on the causes of Rett syndrome.
    Caballero IM; Hendrich B
    Hum Mol Genet; 2005 Apr; 14 Spec No 1():R19-26. PubMed ID: 15809268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A transcriptional repressor MeCP2 causing Rett syndrome is expressed in embryonic non-neuronal cells and controls their growth.
    Nagai K; Miyake K; Kubota T
    Brain Res Dev Brain Res; 2005 Jun; 157(1):103-6. PubMed ID: 15939091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
    Chen RZ; Akbarian S; Tudor M; Jaenisch R
    Nat Genet; 2001 Mar; 27(3):327-31. PubMed ID: 11242118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.
    Samaco RC; Hogart A; LaSalle JM
    Hum Mol Genet; 2005 Feb; 14(4):483-92. PubMed ID: 15615769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analyses of MeCP2 mutations associated with Rett syndrome using transient expression systems.
    Kudo S; Nomura Y; Segawa M; Fujita N; Nakao M; Dragich J; Schanen C; Tamura M
    Brain Dev; 2001 Dec; 23 Suppl 1():S165-73. PubMed ID: 11738866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry.
    LaSalle JM; Goldstine J; Balmer D; Greco CM
    Hum Mol Genet; 2001 Aug; 10(17):1729-40. PubMed ID: 11532982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome.
    Wan M; Zhao K; Lee SS; Francke U
    Hum Mol Genet; 2001 May; 10(10):1085-92. PubMed ID: 11331619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype.
    Hoffbuhr KC; Moses LM; Jerdonek MA; Naidu S; Hoffman EP
    Ment Retard Dev Disabil Res Rev; 2002; 8(2):99-105. PubMed ID: 12112735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice.
    Luikenhuis S; Giacometti E; Beard CF; Jaenisch R
    Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6033-8. PubMed ID: 15069197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.
    Amir RE; Van den Veyver IB; Wan M; Tran CQ; Francke U; Zoghbi HY
    Nat Genet; 1999 Oct; 23(2):185-8. PubMed ID: 10508514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders.
    Samaco RC; Nagarajan RP; Braunschweig D; LaSalle JM
    Hum Mol Genet; 2004 Mar; 13(6):629-39. PubMed ID: 14734626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the gene encoding methyl-CpG-binding protein 2 cause Rett syndrome.
    Van den Veyver IB; Zoghbi HY
    Brain Dev; 2001 Dec; 23 Suppl 1():S147-51. PubMed ID: 11738862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association by guilt: identification of DLX5 as a target for MeCP2 provides a molecular link between genomic imprinting and Rett syndrome.
    Bapat S; Galande S
    Bioessays; 2005 Jul; 27(7):676-80. PubMed ID: 15954098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome.
    Horike S; Cai S; Miyano M; Cheng JF; Kohwi-Shigematsu T
    Nat Genet; 2005 Jan; 37(1):31-40. PubMed ID: 15608638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.